or
Remember me
Back
This report from RTI really solidifies Asep Medical’s (CSE: ASEP) market opportunity as a developer of novel sepsis diagnostic and therapeutic solutions.
Given the prevalence of sepsis, the report reveals improved treatment and diagnostic solutions could result in an overall savings of up to $22 billion annually in the US alone.
$ASEP.c is currently performing formal studies for its Sepset diagnostic solution and is expecting to file a 510(k) application in the latter half of 2022. I’m highly anticipating updates on this as a big catalyst.
$ASEP.c is currently trading at $.35 and is valued at $19.65M.
https://ca.finance.yahoo.com/news/asep-medical-holdings-inc-announces-120000639.html
Receive investor kits and email updates from Stockhouse and directly from these companies.